Sharda Cropchem Ltd: Intrinsic Value & Share Price Analysis

Fair Value

₹717.96Fairly Valued by 5.28%vs CMP ₹758.00

P/E (10.9) × ROE (23.2%) × BV (₹348.00) × DY (1.98%)

₹668.26Overvalued by 11.84%vs CMP ₹758.00

MoS: -13.4% (Negative)Confidence: 48/100 (Moderate)Models: 1 Under, 3 Fair, 5 Over

Model	Category	Value	Weight	Signal
PE-ROE	Earnings	₹790.71	22%	Fair (+4.3%)
Graham Number	Earnings	₹700.78	16%	Fair (-7.5%)
Earnings Power	Earnings	₹244.76	11%	Over (-67.7%)
DCF	Cash Flow	₹1,048.09	13%	Under (+38.3%)
Net Asset Value	Assets	₹347.58	7%	Over (-54.1%)
EV/EBITDA	Enterprise	₹789.14	9%	Fair (+4.1%)
Earnings Yield	Earnings	₹627.20	7%	Over (-17.3%)
ROCE Capital	Returns	₹524.26	9%	Over (-30.8%)
Revenue Multiple	Revenue	₹478.81	5%	Over (-36.8%)
Consensus (9 models)		₹668.26	100%	Overvalued

Key Drivers: Wide model spread (₹245–₹1,048) — high uncertainty.

PE-ROE · Graham · EPV · DCF · NAV · EV/EBITDA · DDM · Earnings Yield · ROCE Capital · Revenue Multiple | CoE: 12% · Terminal: 4% · EPS CAGR: 10.1%

*Investments are subject to market risks

Analysis summary

Data coverage: Price-data record updated 24 September 2026, 3:30 am +05:30. Annual results through Mar 2025; quarterly results through Dec 2025; cash flow through Mar 2026. Each section can have a different reporting period. The share price is not live.

Valuation in context

Operating performance

Revenue for Mar 2025 was ₹4,320.00 Cr, versus ₹3,163.00 Cr in Mar 2024 (36.6% year on year). Net profit for Mar 2025 was ₹304.00 Cr, versus ₹32.00 Cr in Mar 2024 (850.0% year on year). These are the latest annual periods stored on this page; check the quarterly table separately for more recent developments.

Cash generation

For the same Mar 2025 period, operating cash flow was ₹604.00 Cr against net profit of ₹304.00 Cr. Cash flow covered 1.99 times reported profit. Cash generation supports the reported profit for this period; check whether this continues over several years.

Balance-sheet check

Reported borrowings were ₹0.00 Cr in Mar 2026. Read this alongside cash, interest costs and repayment obligations; reserves are an accounting balance and are not the same as available cash.

How to use the valuation and peer comparisons

The Intrinsic Value panel combines the available model estimates using the displayed weights. Earnings, cash-flow, dividend and asset-based methods can give very different answers. The displayed 12% cost of equity and 4% terminal growth assumptions apply where relevant; historical EPS growth is not a promise of future growth. Use the individual values and their spread to judge sensitivity.

The peer group follows the stored industry classification and may include different business models. Compare reporting periods, leverage and recurring earnings before interpreting a valuation gap. For banks and other financial businesses, capital adequacy and asset quality can be more informative than industrial-company cash-flow ratios.

Sources: Company data source. Check the company filings linked by the source for the reporting basis and exceptional items.

Automatically generated interpretation of the stored financial data, not a separately researched analyst opinion. Missing data is not evidence of poor performance. New filings become available here after the existing data refresh process captures them.

Investment Snapshot

Sharda Cropchem Ltd scores 82/100 (Strong)

Based on 5 dimensions: health, institutional flow, earnings quality, momentum, and peer comparison

Stock Health100/100 · Strong

ROCE 30.2% ExcellentROE 23.2% ExcellentD/E 0.00 Low debtInterest Coverage 311.1x StrongProfitable 5/5 available years Reported history

Smart Money30/100 · Weak

FII holding down -2.14% (6mo) SellingPromoter holding at 74.8% Stable

Earnings Quality65/100 · Strong

CFO/NP ratio: 1.88x Cash-backed earningsOPM contracting (18% → 12%) Declining

Quarterly Momentum100/100 · Strong

Revenue (4Q): +32% YoY AcceleratingProfit (4Q): +133% YoY StrongOPM: 19.0% (up 7.0% YoY) Margin expansion

Industry Rank85/100 · Strong

P/E 10.9 vs industry 30.1 Lower P/EROCE 30.2% vs industry 15.5% Above peersROE 23.2% vs industry 15.4% Above peers3Y sales CAGR: 6% Slow

Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores use stored reporting periods and are screening indicators, not investment recommendations. Missing health ratios are excluded. Broad industry groups and financial-sector accounting can limit comparability.

Share Price and Basic Stock Data

Last Updated: September 24, 2026, 3:30 am

Market Cap	6,839 Cr.
Current Price	758
Intrinsic Value	₹668.26
High / Low	1,298/737
Stock P/E	10.9
Book Value	348
Dividend Yield	1.98 %
ROCE	30.2 %
ROE	23.2 %
Face Value	10.0
PEG Ratio	1.08

Understand these figures: how to read the P/E ratio, ROE versus earnings per share, and calculate intrinsic value.

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Sharda Cropchem Ltd

Competitors

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
Sharda Cropchem Ltd	6,839 Cr.	758	1,298/737	10.9	348	1.98 %	30.2 %	23.2 %	10.0
Epigral Ltd	4,718 Cr.	1,094	1,771/806	17.4	515	0.46 %	15.3 %	15.8 %	10.0
Dhanuka Agritech Ltd	4,389 Cr.	983	1,620/890	15.0	311	0.20 %	28.3 %	22.0 %	2.00
Rallis India Ltd	3,940 Cr.	203	320/197	17.2	105	1.48 %	14.1 %	10.2 %	1.00
NACL Industries Ltd	3,261 Cr.	139	245/113	126	29.2	0.00 %	8.13 %	2.37 %	1.00
Industry Average	8,982.90 Cr	968.36		30.11	378.31	0.61%	15.52%	15.36%	6.67

All Competitor Stocks of Sharda Cropchem Ltd

Quarterly Result

Metric	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Sales	1,017	1,482	638	581	632	1,312	785	777	929	1,829	985	929	1,289
Expenses	810	1,164	697	560	563	1,057	708	687	815	1,525	770	796	1,048
Operating Profit	207	318	-59	21	69	255	77	90	115	303	215	133	241
OPM %	20%	21%	-9%	4%	11%	19%	10%	12%	12%	17%	22%	14%	19%
Other Income	3	7	26	24	12	-2	19	25	1	25	32	29	21
Interest	1	2	1	5	1	0	1	0	0	0	1	0	0
Depreciation	65	68	70	74	69	54	65	69	69	72	78	76	83
Profit before tax	143	255	-105	-34	12	198	31	46	46	256	169	86	179
Tax %	24%	22%	-15%	-18%	62%	28%	11%	7%	32%	20%	16%	13%	19%
Net Profit	108	199	-89	-28	5	143	27	42	31	204	143	74	145
EPS in Rs	12.01	22.04	-9.82	-3.06	0.51	15.90	3.02	4.70	3.45	22.56	15.83	8.24	16.09

Last Updated: February 4, 2026, 6:16 am

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 25, 2026, 6:46 pm

Metric	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	790	1,061	1,222	1,399	1,707	1,998	2,003	2,396	3,580	4,045	3,163	4,320	5,031
Expenses	630	878	941	1,075	1,343	1,621	1,653	1,945	2,884	3,386	2,860	3,705	4,139
Operating Profit	160	183	281	324	364	376	350	450	696	659	303	615	892
OPM %	20%	17%	23%	23%	21%	19%	17%	19%	19%	16%	10%	14%	18%
Other Income	32	25	23	14	9	-22	-12	46	29	40	60	60	108
Interest	8	9	8	9	15	20	16	16	15	20	24	21	2
Depreciation	29	23	35	56	70	99	137	170	245	248	267	275	309
Profit before tax	155	175	261	272	287	235	185	309	464	431	72	378	690
Tax %	29%	30%	33%	30%	34%	25%	11%	26%	25%	21%	56%	20%
Net Profit	111	123	175	190	191	176	165	229	349	342	32	304	566
EPS in Rs	12.31	13.63	19.41	21.11	21.14	19.55	18.25	25.40	38.71	37.90	3.53	33.74	62.72
Dividend Payout %	16%	18%	21%	19%	19%	20%	22%	20%	16%	16%	85%	27%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2014-2015	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024	2024-2025
YoY Net Profit Growth (%)	10.81%	42.28%	8.57%	0.53%	-7.85%	-6.25%	38.79%	52.40%	-2.01%	-90.64%	850.00%
Change in YoY Net Profit Growth (%)	0.00%	31.47%	-33.70%	-8.05%	-8.38%	1.60%	45.04%	13.61%	-54.41%	-88.64%	940.64%

Sharda Cropchem Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:	15%
5 Years:	17%
3 Years:	6%
TTM:	37%

Compounded Profit Growth
10 Years:	10%
5 Years:	8%
3 Years:	-5%
TTM:	184%

Stock Price CAGR
10 Years:	12%
5 Years:	27%
3 Years:	21%
1 Year:	65%

Return on Equity
10 Years:	15%
5 Years:	12%
3 Years:	10%
Last Year:	13%

Last Updated: September 5, 2025, 1:26 pm

Balance Sheet

Last Updated: July 20, 2026, 1:30 am

Month	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	90	90	90	90	90	90	90	90	90	90	90	90
Reserves	564	715	870	1,045	1,194	1,313	1,524	1,822	2,142	2,147	2,410	3,046
Borrowings	38	2	0	170	0	0	81	47	3	18	8	0
Other Liabilities	354	522	686	914	914	940	1,163	1,779	2,108	1,773	2,205	2,620
Total Liabilities	1,047	1,329	1,646	2,219	2,198	2,343	2,858	3,738	4,343	4,028	4,713	5,757
Fixed Assets	88	130	210	226	372	416	544	592	668	708	750	989
CWIP	149	210	232	360	220	161	131	212	204	283	291	247
Investments	95	90	61	22	212	116	83	134	32	159	294	361
Other Assets	715	899	1,143	1,611	1,394	1,650	2,099	2,800	3,439	2,878	3,377	4,159
Total Assets	1,047	1,329	1,646	2,219	2,198	2,343	2,858	3,738	4,343	4,028	4,713	5,757

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity +	46	197	181	17	556	146	246	267	328	341	604	656
Cash from Investing Activity +	-19	-113	-104	-160	-351	-59	-282	-205	-112	-393	-496	-445
Cash from Financing Activity +	-24	-89	-38	132	-215	-60	43	-91	-97	-37	-68	-118
Net Cash Flow	3	-6	40	-11	-11	27	8	-29	120	-89	40	93
Free Cash Flow	-34	196	39	-185	413	-30	15	33	84	69	211	158
CFO/OP	58%	95%	73%	27%	169%	60%	68%	49%	60%	129%	103%	68%

Free Cash Flow

Free cash flow reported in the stored cash-flow statement (₹ Cr)
Period	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Free Cash Flow	-34.00	196.00	39.00	-185.00	413.00	-30.00	15.00	33.00	84.00	69.00	211.00	158.00

This table and the chart use the Free Cash Flow row from the same stored cash-flow statement. Free cash flow generally measures operating cash flow after capital expenditure; check the source definition and reporting basis. It is not operating profit minus borrowings.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Debtor Days	185	156	185	175	191	148	180	177	157	165	173	165
Inventory Days	57	72	74	117	169	96	100	117	130	145	155	117
Days Payable	146	117	179	186	202	167	180	180	172	176	144	158
Cash Conversion Cycle	97	111	81	106	158	77	100	114	115	134	184	124
Working Capital Days	67	82	95	99	94	71	101	94	88	97	128	92
ROCE %	28%	27%	36%	32%	27%	23%	18%	21%	26%	21%	4%	16%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoters	74.82%	74.82%	74.82%	74.82%	74.82%	74.82%	74.82%	74.82%	74.82%	74.82%	74.82%	74.82%
FIIs	2.01%	2.06%	2.14%	2.02%	2.52%	3.77%	4.69%	5.48%	5.26%	4.20%	4.60%	3.12%
DIIs	12.29%	12.42%	12.41%	12.87%	12.77%	10.07%	10.28%	9.38%	9.26%	9.95%	9.70%	9.18%
Public	10.87%	10.70%	10.63%	10.29%	9.91%	11.33%	10.21%	10.33%	10.65%	11.02%	10.88%	12.88%
No. of Shareholders	56,483	56,858	61,075	54,436	48,353	58,717	51,187	62,030	67,290	65,567	61,155	63,572

Shareholding Pattern Chart

No. of Shareholders

Sharda Cropchem Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

Mutual Fund Holdings

Fund Name	No of Shares	AUM (%)	Amount Invested (Cr)	Previous Number of Shares	Previous Date	Percentage Change
HDFC Small Cap Fund	5,406,610	1.52	560.04	N/A	N/A	N/A
HDFC Hybrid Equity Fund	920,000	0.4	95.3	846,062	2025-12-15 00:39:12	8.74%
Bandhan Balanced Advantage Fund	46,426	0.21	4.81	34,622	2026-02-22 21:48:05	34.09%

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	33.74	3.53	37.90	38.71	25.40
Diluted EPS (Rs.)	33.74	3.53	37.90	38.71	25.40
Cash EPS (Rs.)	64.19	33.15	65.41	65.91	44.30
Book Value[Excl.RevalReserv]/Share (Rs.)	277.16	248.00	247.44	212.01	178.96
Book Value[Incl.RevalReserv]/Share (Rs.)	277.16	248.00	247.44	212.01	178.96
Revenue From Operations / Share (Rs.)	478.81	350.59	448.36	396.78	265.53
PBDIT / Share (Rs.)	72.61	37.98	75.74	78.89	53.50
PBIT / Share (Rs.)	42.17	8.37	48.24	51.70	34.61
PBT / Share (Rs.)	41.93	7.97	47.74	51.46	34.30
Net Profit / Share (Rs.)	33.74	3.54	37.91	38.71	25.41
NP After MI And SOA / Share (Rs.)	33.74	3.53	37.90	38.71	25.40
PBDIT Margin (%)	15.16	10.83	16.89	19.88	20.14
PBIT Margin (%)	8.80	2.38	10.75	13.03	13.03
PBT Margin (%)	8.75	2.27	10.64	12.96	12.91
Net Profit Margin (%)	7.04	1.00	8.45	9.75	9.56
NP After MI And SOA Margin (%)	7.04	1.00	8.45	9.75	9.56
Return on Networth / Equity (%)	12.17	1.42	15.32	18.26	14.19
Return on Capital Employeed (%)	13.88	3.07	18.28	22.73	18.10
Return On Assets (%)	6.44	0.78	7.85	9.33	8.00
Total Debt / Equity (X)	0.00	0.00	0.00	0.01	0.04
Asset Turnover Ratio (%)	0.98	0.75	0.85	0.93	0.80
Current Ratio (X)	1.81	1.86	1.65	1.69	1.84
Quick Ratio (X)	1.32	1.23	1.08	1.16	1.38
Inventory Turnover Ratio (X)	4.40	1.40	1.59	1.96	2.19
Dividend Payout Ratio (NP) (%)	18.16	85.75	16.21	15.49	7.87
Dividend Payout Ratio (CP) (%)	9.54	9.14	9.39	9.10	4.51
Earning Retention Ratio (%)	81.84	14.25	83.79	84.51	92.13
Cash Earning Retention Ratio (%)	90.46	90.86	90.61	90.90	95.49
Interest Coverage Ratio (X)	311.10	94.68	151.52	321.65	174.12
Interest Coverage Ratio (Post Tax) (X)	145.56	9.82	76.83	158.84	83.69
Enterprise Value (Cr.)	4929.40	2811.46	4234.14	5420.45	2398.75
EV / Net Operating Revenue (X)	1.14	0.88	1.05	1.51	1.00
EV / EBITDA (X)	7.52	8.21	6.20	7.62	4.97
MarketCap / Net Operating Revenue (X)	1.19	0.91	1.09	1.55	1.08
Retention Ratios (%)	81.83	14.24	83.78	84.50	92.12
Price / BV (X)	2.06	1.29	1.98	2.90	1.61
Price / Net Operating Revenue (X)	1.19	0.91	1.09	1.55	1.08
EarningsYield	0.05	0.01	0.07	0.06	0.08

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Frequently asked questions

What is the intrinsic value of Sharda Cropchem Ltd and is it undervalued?

Sharda Cropchem Ltd: the stored intrinsic value estimate is ₹668.26, compared with a stored share price of ₹758.00. The model value is 11.8% below that quote. The model classifies this as overvalued; it is an estimate dependent on the inputs and assumptions, not a price target or a buy/sell recommendation. The estimate uses the available valuation models and weights shown in the Intrinsic Value panel, including earnings, cash-flow and asset-based approaches where data permits. It is not a P/E-only calculation.

What share price and 52-week range are shown for Sharda Cropchem Ltd?

The stored share price is ₹758.00. Price-data record updated: 24 September 2026, 3:30 am +05:30. This is not a live quote. The stored 52-week high / low is 1,298/737; this is a rolling range, not a financial-year range.

How have Sharda Cropchem Ltd's revenue and profit changed?

Does Sharda Cropchem Ltd's profit convert into cash?

What should I check in Sharda Cropchem Ltd's balance sheet?

Reported borrowings were ₹0.00 Cr in Mar 2026. Read this alongside cash, interest costs and repayment obligations; reserves are an accounting balance and are not the same as available cash.

How should I compare Sharda Cropchem Ltd's P/E with other stocks?

The stored P/E is 10.90. Compare companies with similar business models, growth, leverage and accounting periods. The industry group on this page is broad, and its average can be affected by outliers. A lower P/E alone does not establish undervaluation.

What could change Sharda Cropchem Ltd's intrinsic value estimate?

Changes in sustainable earnings, cash generation, capital needs, debt and share count can change the estimate. The displayed model uses a 12% cost of equity and 4% terminal growth assumption where applicable. Higher discount rates or weaker growth generally reduce discounted values. Compare the individual model values and weights, and verify fresh filings before relying on the result.